The overarching mission of the OHSU Department of Cell, Developmental & Cancer Biology is to advance the understanding of problems relevant to human health and disease. To accomplish this mission, research groups in the department have historically focused on questions regarding cell structure, organelles, life cycle, differentiation, and regulated communication between cells and extracellular signals and cues. An ultimate application of knowledge gained from these studies has been to understand important cell physiologic processes that effect human biology. These issues directly link to problems of interest to developmental biologists, including molecular and cellular mechanisms regulating tissue morphogenesis, tissue polarity and patterning. Read full welcome message here.
Welcoming new members during modified operations
Many new faces have joined us since OHSU's modified operations began in March 2020. We have created a page where you will find a photo and bio for faculty, staff, and students who have joined during this time. Visit the page here.
OHSU Respect For All Flowchart
Quantitative and Systems Biology Program Symposium
A series of short talks highlighting both the diversity and commonalities among quantitative work at OHSU. Speakers will be drawn from a range of disciplines. September 20th, 2021 from 9:00am - 12:30pm. More details to come.
At AACR's Tumor Immunology and Immunotherapy event in November, CDCB research presented their research.
Recent Accolades & Funding
Congratulations to Karin Rodland, Ph.D. who has recently received the PNNL Lab Director’s Award for Lifetime Achievement in Science or Technology.
Congratulations to Missy Wong, Ph.D. and the Wong lab whose paper, "Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors," published in Scientific Reports is the School of Medicine's Paper of the Month. Read the story on OHSU Now.
Congratulations to the following postdoctoral and predoctoral trainees who have been awarded the T32 training grant from CDCB: Tahereh Ziglari, PhD, postdoctoral scholar in the Pucci lab, Benjamin Sarno, PhD, postdoctoral scholar in the Mills lab, Katie Blise, graduate student in the Goecks lab, and Mona Mohammadhosseini, graduate student in the Agarwal lab. Learn more about the T32 training program and trainee projects here.
Congratulation to Philip Copenhaver, Ph.D. who has been awarded the Allan J. Hill, Jr. Award for Basic Science. The award recognizes excellence in teaching by honoring a full-time faculty member in basic science.
Amy Moran, Ph.D. and Megan Ruhland, Ph.D. are contributors on a recently published symposium commentary, "Arthur L. Irving Family Foundation Cancer Immunology Symposium: Supporting the next generation of scientists to lead cancer immunology research," in Cancer Immunology Research. Please come back later for a link to the paper.
Amy Moran, Ph.D. is a contributor on a recently published paper, "Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data," in Nature Biotech. Please come back later for a link to the paper.
View all CDCB news and recognitions.
CDCB is excited to welcome Sanjay Malhotra, Ph.D. Dr. Malhotra is joining us as a professor and will co-lead the Knight Cancer Institute's new center, the Center for Experimental Therapeutics. Dr. Malhotra's background is in chemical biology and drug development with a strong expertise in medicinal chemistry, including small molecule synthesis. Visit the Malhotra lab website to learn more. Welcome, Dr. Malhotra!
CDCB is pleased to announce that Jonathan Brody, Ph.D., will be joining us as a joint faculty member as a professor with the Department of Surgery and Cell, Developmental & Cancer Biology. The main focus of Dr. Brody's laboratory is to understand the molecular aspects of pancreatic cancer cells and find novel therapeutic strategies for pancreatic cancer patients. Visit the Brody lab website to learn more. Welcome, Dr. Brody!
CDCB would like to welcome Robert Eil, M.D., who will be joining us as a joint faculty member with the Department of Surgery. Dr. Eil is an assistant professor as well as the Knight Cancer Institute's Director of Solid Tumor Surgical Immuno-oncology. Dr. Eil is a surgeon-scientist with a long-term goal of applying T cell-based immunotherapy to cancers involving the liver. Visit the Eil lab website to learn more. Welcome, Dr. Eil!
CDCB is pleased to announce that Megan Ruhland, Ph.D. will be joining the department as an Assistant Professor with a focus on tumor immunology. She joins us now from the University of California, San Francisco where she was a CRI Irvington Postdoctoral Fellow. Visit the Ruhland lab website to learn more. Welcome, Dr. Ruhland!